Transparency Market Research Report Added "Orthopedic Biomaterials Market" to its database.
Albany, NY -- (SBWIRE) -- 12/01/2014 -- Orthopedic biomaterials are organic or synthetic materials of biologic composition used for internal fixation of fracture. Biomaterial devices which are manufactured for large number of orthopedic applications are commonly termed as 'Implants'. These biomaterials help in re-establishing the structural integrity of the damaged bone due to trauma or diseased conditions. Biocompatibility of the material is the primary factor to be considered before its usage in orthopedic applications. Other characteristics on which the success of biomaterials in biological applications depends on the choice of material for its construction, appropriate design, stability and various properties like hardness and tensile strength and their interaction with soft and hard tissues and intra and extracellular fluids of the human body and blood.
Browse Full Report with TOC:
The orthopedic biomaterials market is categorized on the type of biomaterial, its application and by geography. The major types of biomaterials used in the orthopedic applications are divided into two groups; metals and non-metals:
Stainless steels: 316L
Titanium and titanium-base alloys
The orthopedic implants by application are categorized as follows:
Bioresorbable tissue fixation products
Nonconventional modular tumor implants
Globally, North America dominates the orthopedic biomaterials market due to increase in aging population and is followed by European countries, Asia and rest of the world. Developing countries in Asia such as China and Taiwan are expected to undergo rapid market growth due to rising awareness of biodegradable products, vigorous research-related activities, collaborations and undertaking of various health conferences and conventions both by governments and private bodies.
Read More Research Report on Chemical & Materials Market:
One of the major drivers for this market is the vigorous ongoing research in development of biomaterials and its widened scope of applications. Other factors driving the orthopedic biomaterials market include increase in investments for novel development, government initiative of funding and grants, advancement in technologies and increase in elderly population. The key deterrents responsible for curbing the market growth are lack of data for long term performance of clinical studies, stringent regulatory laws, post implantation issues such as fracture fatigue and dicey reimbursement policies.
Some of the key players in orthopedic biomaterials market are Carpenter Technology Corporation, Materion Corporation, Ulbrich Stainless Steel & Special Metals, Inc., Heraeus Medical Components, CeramTec (a subsidiary of Rockwood Holdings Inc.), Ceradyne, Inc., Kyocera Corporation, Bayer, Purac Biomaterials, DSM Biomedical, Inc., Evonik Industries AG, Cam Bioceramics B.V., Ticona GmbH, Osteotech, Inc., Starch Medical, Inc. and Landec Corporation.
Enquiry Before Buying:
About Transparency Market Research
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453